Brief: China Regenerative Medicine International Says Entered MoU With Jinxin Holdings
22/03/2021 15:31
March 22 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* ENTERED MOU WITH JINXIN HOLDINGS
* MOU FOR POSSIBLE JOINT DEVELOPMENT OF A HEALTHCARE
INDUSTRIAL
PARK IN PRC
* CO SHALL HAVE RIGHT TO INVEST IN AN AGGREGATE TOTAL OF UP
TO 50%
EQUITY INTEREST IN TARGET CO
* JINXIN FORMED CHANGZHOU ZHONGZAISHENG HEALTHCARE INDUSTRY
DEVELOPMENT CO TO DEVELOP HEALTHCARE PARK
Source text for Eikon: urn:newsml:reuters.com:*:nHKS93ws7H
Further company coverage: 8158.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital